Impact of Clomiphene Citrate Administration During the Early Luteal Phase on Endocrine Profile in IVF Cycles

Impact of Clomiphene Citrate Administration During the Early Luteal Phase on Endocrine Profile in Agonist Triggered GnRH Antagonist in Vitro Fertilization Cycles. Phase IV, Single-centre, Open-label, Controlled Clinical Trial.

The purpose of this study is to evaluate the effect on LH levels of the 5-day CC administration during luteal phase in oocyte donors, to investigate whether the CC corrects the suppressed LH levels in the luteal phase and whether it prolongs the luteal phase in the agonist triggered antagonist cycles.

Inclusion Criteria:

• Oocyte donors
• 18-35 years old
• BMI 18-29 Kg/m2
• Normal basal hormonal levels
• No contraceptive pill

Exclusion Criteria:

• Polycystic ovarian syndrome (PCOS)
• Previous participation in the study